Hepatitis C: Enhancing treatment for hepatitis C among drug users

Nature Reviews Gastroenterology and Hepatology

Volumn 8, Issue 1, 2011, Pages 11-13

  Grebely, Jason ^a   Dore, Gregory J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG; PEGINTERFERON ALPHA2B PLUS RIBAVIRIN;

AWARENESS; CLINICAL PRACTICE; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG USE; HEALTH CARE PERSONNEL; HEPATITIS C; HUMAN; MEDICAL EDUCATION; PATIENT CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT INDICATION; TREATMENT RESPONSE;

ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; DRUG USERS; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; PATIENT COMPLIANCE; POLYETHYLENE GLYCOLS; RIBAVIRIN;

EID: 78651084478     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2010.186     Document Type: Review

References (10)

1. shepard, C. w., Finelli, L. & Alter, M. J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5, 558-567 (2005).
2. Manns, M. P., wedemeyer, H. & Cornberg, M. Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55, 1350-1359 (2006).
3. niH. national institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 26, 2s-10s (1997).
4. sylvestre, D. L. Treating hepatitis C in methadone maintenance patients: an interim analysis. Drug Alcohol Depend. 67, 117-123 (2002).
5. Backmund, M., Meyer, K., von Zielonka, M. & eichenlaub, D. Treatment of hepatitis C infection in injection drug users. Hepatology 34, 188-193 (2001).
6. niH. niH Consensus statement on Management of Hepatitis C: 2002. NIH Consens. State Sci. Statements 19, 1-46 (2002).
7. Grebely, J., devlaming, s., Duncan, F., viljoen, M. & Conway, B. Current approaches to HCv infection in current and former injection drug users. J. Addict. Dis. 27, 25-35 (2008).
8. Melin, P. et al. effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study. Eur. J. Gastroenterol. Hepatol. 22, 1050-1057 (2010).
9. Hellard, M., sacks-Davis, R. & Gold, J. Hepatitis C treatment for injection drug users: a review of the available evidence. Clin. Infect. Dis. 49, 561-573 (2009).
10. Grebely, J. et al. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug Alcohol Depend. 93, 141-147 (2008).